CSIMarket Company Name, Ticker, Suppliers, else..
 
Treace Medical Concepts Inc   (TMCI)
Other Ticker:  
 
 
Price: $8.2800 $-0.01 -0.121%
Day's High: $8.75 Week Perf: 3.76 %
Day's Low: $ 8.17 30 Day Perf: 71.07 %
Volume (M): 834 52 Wk High: $ 15.98
Volume (M$): $ 6,906 52 Wk Avg: $8.80
Open: $8.27 52 Wk Low: $3.92



 Market Capitalization (Millions $) 515
 Shares Outstanding (Millions) 62
 Employees -
 Revenues (TTM) (Millions $) 203
 Net Income (TTM) (Millions $) -62
 Cash Flow (TTM) (Millions $) 5
 Capital Exp. (TTM) (Millions $) 11

Treace Medical Concepts Inc
Treace Medical Concepts Inc is a medical device company that focuses on developing innovative solutions for foot and ankle conditions. The company is known for its Laser Loc' and Lapiplasty' product lines, which aim to advance the standard of care for the treatment of various foot and ankle conditions, including bunions and hammertoes. Treace Medical Concepts Inc strives to provide surgeons and patients with improved surgical approaches and outcomes through their technologically advanced and minimally invasive products.


   Company Address: 100 Palmetto Park Place Ponte Vedra 32081 FL
   Company Phone Number: 373-5940   Stock Exchange / Ticker: NASDAQ TMCI


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
• View Complete Report
   



Product Service News

Pioneering Footsteps Treace Medical?s Nanoplasty 3D Boosts Bunion Surgery with Minimally Invasive Precis...

Published Mon, Nov 4 2024 12:00 PM UTC

In the evolving landscape of medical technology, the orthopaedic sector is witnessing groundbreaking advancements. Among the frontrunners of this innovation is Treace Medical Concepts, Inc., which has recently introduced the Nanoplasty 3D, a minimally invasive bunion correction procedure poised to transform the field of bunion surgery.Bunions, a common foot ailment affecting...
Partnership

Innovative Partnership Brings Relief and Performance Enhancement to Pickleball Players with Foot Deformities

Published Wed, Apr 24 2024 11:00 AM UTC

Treace Medical Named First Medical Device Partner and Official Foot and Ankle Solution Partner of the PPA Tour: A Major Breakthrough for the Bunions and Midfoot Deformities CommunityIn a remarkable move that is set to revolutionize the sporting world, Treace Medical has been pronounced as the inaugural medical device partner and official foot and ankle solution partner of th...
Product Service News

Treace Medical Concepts Celebrates 100,000 Successful Lapiplasty 3D Bunion Correction Procedures and Advocates for Awareness on National Bunion Day

Published Mon, Mar 25 2024 11:00 AM UTC

Treace Celebrates 100,000 Lapiplasty 3D Bunion Correction Patient Milestone

Treace Further Expands Focus on Bunion Deformity Education by Sponsoring First-Ever National Bunion Day in the U.S. on April 16, 2024With bunion deformity affecting millions of people worldwide, medical technology company Treace Medical Concepts, Inc. has recently reached a significant...
Clinical Study

Unveiling the Three-Year ALIGN3D Findings: Treace Medical Concepts Confirms Efficacy of Lapiplasty and Adductoplasty Procedures in Bunion Treatment

Published Fri, Feb 2 2024 5:00 PM UTC

In a breakthrough development, Treace Medical Concepts, Inc. (Treace), an innovator at the vanguard of surgical treatment for bunions and related midfoot deformities, has disclosed encouraging findings from its three-year interim clinical data of the ALIGN3D post-market research. This significant step forward in the realm of podiatry was formally announced during a podium pr...
Clinical Study

A Revolutionary Vision: Treace Medical Concepts' New Iterations Pave the Way for Progressive Foot and Ankle Care

Published Thu, Feb 1 2024 12:00 PM UTC

Foot and ankle care is a medical field that never stops evolving, and the driving force behind a notable fraction of this advancement is Treace Medical Concepts Inc. Recently, the company showcased its latest product innovations and disseminated the results of the ALIGN3D study at the 2024 American College of Foot and Ankle Surgeons (ACFAS) Annual Scientific Conference.Among...






Treace Medical Concepts Inc's Segments

  Treace Medical Concepts Inc Outlook

On February 27 2024 the Treace Medical Concepts Inc provided following guidance

Treace Medical Concepts, Inc. (Treace) recently released its financial results for the fourth quarter and full year ended December 31, 2023. The company, which is listed on NasdaqGS under the ticker symbol TMCI, is a leading medical technology firm that is revolutionizing the surgical treatment of bunions and related midfoot deformities with its flagship procedures, Lapiplasty and Adductoplasty.

According to the financial report, Treace experienced strong performance in 2023, with significant growth in revenue and profits. The company's innovative procedures have gained widespread recognition in the medical community and have helped to drive its success in the market.

Looking ahead to 2024, Tre...





Help

About us

Advertise
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com